Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells (original) (raw)
References
Blalock WL, Moye PW, Chang F, Pearce M, Steelman LS, McMahon M and McCubrey JA . (2000b). Leukemia, 14, 1080–1096.
Blalock WL, Pearce M, Chang F, Lee J, Pohnert S, Burrows C, Steelman LS, Franklin RA, McMahon M and McCubrey J . (2001). Leukemia, 15, 794–807.
Blalock WL, Pearce M, Steelman LS, Franklin RA, McCarthy SA, Cherwinski H, McMahon M and McCubrey JA . (2000a). Oncogene, 19, 526–536.
Blalock WL, Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang XY, Algate PA, Franklin RA, Oberhaus SM, Steelman LS and McCubrey JA . (1999). Leukemia, 13, 1109–1166.
Bosch E, Cherwinski H, Peterson D and McMahon M . (1997). Oncogene, 11, 1021–1034.
Carroll MP and May WS . (1994). J. Biol. Chem., 269, 1249–1256.
Chang F and McCubrey JA . (2001). Oncogene, 20, 4353–4364.
Chang F, Steelman LS and McCubrey JA . (2002). Cell Cycle, 1, 220–227.
Chaudhary A, King WG, Mattaliano MD, Frost JA, Diaz B, Morrison DK, Cobb MH, Marshall MS and Brugge JS . (2000). Curr. Biol., 10, 551–554.
Clark SS, McLaughin J, Timmons M, Pendergast AM, Ben-Neriah Y, Dow LW, Crist W, Rovera G, Smith SD and Witte ON . (1988). Science, 239, 775–777.
Craddock BL and Welham MJ . (1997). J. Biol. Chem., 272, 29281–29289.
Dhillon AS, Meikle S, Yazici Z, Eulitz M and Kolch W . (2002a). EMBO J., 21, 64–71.
Dhillon AS, Pollock C, Steen H, Shaw PE, Mischak H and Kolch W . (2002b). Mol. Cell. Biol., 22, 3237–3246.
Duronio V, Scheid MP and Ettinger S . (1998). Cell. Signal.10, 233–239.
Eychene A, Dusanter-Fourt I, Barnier JV, Papin C, Charon M, Gisselbrecht S and Calothy G . (1995). Oncogene, 10, 1159–1165.
Gelfanov VM, Burgess GS, Litz-Jackson S, King AJ, Marshall MS, Nakshatri H and Boswell HS . (2001). Blood, 15, 2508–2517.
Guan K, Figueroa C, Brtva TR, Zhu T, Taylor J, Barber TD and Vojtek AB . (2000). J. Biol. Chem., 275, 27354–27359.
Hoyle PE, Moye PW, Steelman LS, Blalock WL, Franklin RA, Pearce M, Cherwinski H, Bosch E, McMahon M and McCubrey JA . (2000). Leukemia, 14, 642–656.
Kaleko M, Rutter WJ and Miller AD . (1990). Mol. Cell. Biol., 10, 464–473.
Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, Van Aelst L, Wigler MH and Der CJ . (1996). Mol. Cell. Biol., 16, 3923–3933.
Kohn D, Takeuchi F and Roth RA . (1996). J. Biol. Chem., 271, 21920–21926.
Kubota Y, Angelotti T, Niederfellner G, Herbst R and Ullrich A . (1998). Cell Growth Differ., 9, 247–256.
Lloyd AC, Obermuller F, Staddon S, Barth CF, McMahon M and Land H . (1997). Genes Dev., 11, 663–677.
Majewski M, Nieborowska-Skorska M, Salomoni P, Slupianek A, Reiss K, Trotta R, Calabretta B and Skorski T . (1999). Cancer Res., 59, 2815–2819.
Marais R, Light Y, Paterson HF and Marshall CJ . (1995). EMBO J., 14, 3136–3145.
Marshall M . (1995). Mol. Reprod. Dev., 42, 493–499.
McCubrey JA, Blalock WL, Chang F, Steelman LS, Pohnert SC, Navolanic PM, Shelton JG, Hoyle PE, Moye PW, Oberhaus SM, White MK, Lee JT and Franklin RA (2001d). Cell Cycle Checkpoints and Cancer. Blagosklonny M. (ed). Landes Bioscience Press: Austin, TX, pp. 17–51. Google Scholar
McCubrey J, Holland G, McKearn J and Risser R . (1989). Oncogene Res., 4, 97–109.
McCubrey JA, Lee JT, Steelman LS, Blalock WL, Moye PW, Chang F, Pearce M, Shelton JG, White MK, Franklin RA and Pohnert SC . (2001a). Cancer Detect. Prevent., 25, 375–393.
McCubrey JA, May WS, Duronio V and Mufson A . (2000a). Leukemia, 14, 9–21.
McCubrey JA, Steelman LS, Blalock WL, Lee JT, Moye PW, Chang F, Pearce M, Shelton JG, White MK, Franklin RA and Pohnert SC . (2001b). Adv. Enzyme Regul., 41, 289–323.
McCubrey JA, Steelman LS, Hoyle PE, Blalock WL, Weinstein-Oppenheimer C, Franklin RA, Cherwinski H, Bosch E and McMahon M . (1998). Leukemia, 12, 1903–1929.
McCubrey JA, Steelman LS, Mayo MW, Algate PA, Dellow RA and Kaleko M . (1991). Blood, 78, 921–929.
McCubrey JA, Steelman LS, Moye PW, Hoyle PE, Weinstein-Oppenheimer C, Chang F, Pierce M, White MK, Franklin R and Blalock WL . (2000b). Adv. Enzyme Regul., 40, 305–337.
McCubrey JA, Wang XY, Algate PA, Blalock WL and Steelman LS . (2001c). Cell Cycle Checkpoints and Cancer. Blagosklonny M. (ed) Landes Bioscience Press Austin, TX, pp. 1–16. Google Scholar
McIlroy J, Chen D, Wjasow C, Michaeli T and Backer JM . (1997). Mol. Cell. Biol.17, 248–255.
McKearn JP, McCubrey JA and Fagg B . (1985). Proc. Natl. Acad. Sci. USA, 85, 7414–7418.
McMahon M . (2001). Methods Enzymol., 332, 401–417.
Minshall C, Arkins S, Freund GG and Kelly KW . (1996). J. Immunol., 156, 939–947.
Mischak H, Seitz T, Janosch P, Eulitz M, Steen H, Schellerer M, Philipp A and Kolch W . (1996). Mol. Cell. Biol., 16, 5409–5418.
Mizra A, Kohn AD, Roth RA and McMahon . (2000). Cell Growth Diff., 11, 279–292.
Mizutani S, Inouye K, Koide K and Kaziro Y (2001). FEBS Lett., 507, 295–298.
Morgenstern JP and Land H . (1990). Nucleic Acids Res., 18, 3587–3596.
Moye PW, Blalock WL, Hoyle PE, Chang F, Franklin RA, Weinstein-Oppenheimer C, Pearce M, Steelman L, McMahon M and McCubrey JA . (2000). Leukemia, 14, 1060–1079.
Rapp UR, Huleihel M, Pawson T, Linnoila I, Minna JD, Heidecker G, Cleveland JL, Beck T, Forchhammer J and Storm SM . (1988). Lung Cancer, 4, 162–167.
Rodriguez-Viciana P, Marte BM, Warne PH and Downward J . (1996). Philos. Trans. Roy. Soc. London Series B: Biol. Sci., 351, 225–231.